Pray
David A. Pray, Bellbrook, OH US
Patent application number | Description | Published |
---|---|---|
20080246260 | GAS CONTAINMENT AND RELEASE DEVICE FOR AN INFLATOR - A containment device for an inflator, the containment device comprising: an outlet plate having an outlet opening; a burst disk disposed over the outlet opening; an initiator having a support member; a movable support disposed between the support member and the burst disk, the support providing support to the burst disk; wherein activation of the initiator causes the movable support to move which allows the burst disk to rupture. | 10-09-2008 |
Jeffery S. Pray, Shenandoah, TX US
Patent application number | Description | Published |
---|---|---|
20150308218 | EXTRUSION GAP REDUCTION DEVICE AND METHOD FOR REDUCING AN EXTRUSION GAP - An extrusion gap reduction device includes an outer housing; an inner housing movably disposed relative to the outer housing. A plurality of petals movably connected to the inner housing. One or more of the plurality of petals including a follower responsive to a cam surface of the outer housing. | 10-29-2015 |
Scott Pray, Centerville, MA US
Patent application number | Description | Published |
---|---|---|
20160059388 | SANDING CLOTHS - A sanding cloth is provided. The sanding cloth comprises a sheet of pliable material having a first side and a second side. An amount of first is adhesive applied to the first side of the sheet. A first grit material is applied to the first adhesive wherein the sheet is easily pliable and conformable to tight fine spaces that are sanded when preparing trim moldings, furniture refinishing and similar finish applications. | 03-03-2016 |
Todd Pray, San Mateo, CA US
Patent application number | Description | Published |
---|---|---|
20080306074 | Compositions Comprising Addl Receptors, Related Compositions, and Related Methods - Disclosed and claimed herein are compositions comprising ADDL receptors, related compositions, and related methods. ADDL receptors are typically, but perhaps not exclusively, localized at the post-synaptic density (PSD) of neuronal cells. Related compositions include, but are not limited to, compounds that affect, positively or negatively, ADDL binding to neuronal cells, either via one or more receptors localized at the post-synaptic density (PSD) or otherwise. Related methods include, but are not limited to, procedures to screen for compounds that affect, either positively or negatively, ADDL binding to neuronal cells, either via one or more receptors localized at the post-synaptic density (PSD) or otherwise. Other related methods include, but are not limited to, prevention and treatment of ADDL-related diseases, such as Alzheimer's disease, mild cognitive impairment, Down's syndrome, and the like, using compositions that inhibit, block, or otherwise interfere with ADDL binding to one or more receptors localized at the post-synaptic density of neuronal cells. | 12-11-2008 |
20090018084 | METHODS OF RESTORING COGNITIVE ABILITY USING NON-PEPTIDIC COMPOUNDS - Disclosed are methods of enhancing cognitive impairment in a patient wherein the cognitive impairment is due to ADDL neurotoxicity. The methods employ non-peptidic compounds having a molecular weight of less than 1000 and which can antagonize against formation of neurotoxic ADDLs from Aβ | 01-15-2009 |
20090018218 | METHODS OF MODIFYING AMYLOID beta OLIGOMERS USING NON-PEPTIDIC COMPOUNDS - Disclosed are methods of inhibiting, regulating, and/or modulating the formation of soluble, globular, non-fibrillar, neurotoxic amyloid β | 01-15-2009 |
20110098309 | METHODS OF INHIBITING THE FORMATION OF AMYLOID-BETA DIFFUSABLE LIGANDS USING ACYLHYDRAZIDE COMPOUNDS - Disclosed are methods of inhibiting, regulating, and/or modulating the formation of soluble, globular, non-fibrillar, neurotoxic amyloid β1-42 oligomers from amyloid β1-42 monomers using acylhydrazide compounds. Also disclosed are methods of treating a patient suffering from diseases associated with the formation of soluble, globular, non-fibrillar, neurotoxic amyloid β1-42 oligomers using acylhydrazide compounds. | 04-28-2011 |
Todd R. Pray, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20090263831 | UBIQUITIN LIGASE ASSAY - The invention relates to assays for measuring ubiquitin ligase activity and for identifying modulators of ubiquitin ligase enzymes. | 10-22-2009 |
Todd R. Pray, San Mateo, CA US
Patent application number | Description | Published |
---|---|---|
20080261819 | IN VIVO PRODUCTION OF CYCLIC PEPTIDES FOR INHIBITING PROTEIN-PROTEIN INTERACTION - The present invention relates to methods and compositions utilizing inteins to generate libraries of cyclic peptides in vivo. The prevent invention also relates to methods for inhibiting protein-protein interaction. | 10-23-2008 |